Asia-Pacific Journal of Clinical Oncology

Papers
(The TQCC of Asia-Pacific Journal of Clinical Oncology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
51
The impact of multidisciplinary cancer meetings in guiding treatment intent in patients with upper tract urothelial carcinoma24
Author List24
Serum miR‐146a level is a potential biomarker in predicting the outcome of diffuse large B‐cell lymphoma21
Primary concurrent chemoradiation therapy with triweekly cisplatin as a standard protocol in patients aged ≥65 years with head and neck squamous cell carcinoma19
Real‐world effectiveness of regorafenib in the treatment of patients with metastatic colorectal cancer: A retrospective, observational study17
Issue Information15
The Best of the Best Oral Abstracts13
Upregulation of O‐GlcNAc transferase is involved in the pathogenesis of acute myeloid leukemia13
Issue Information13
Impact of incorporating Magnetic Resonance Imaging in FIGO Staging of Primary Carcinoma Cervix: Experience from a tertiary cancer center12
12
NATIONAL SPEAKERS10
Safety and potential increased risk of toxicity of radiotherapy combined immunotherapy strategy10
Comparison of direct medical care costs between patients receiving care in a designated palliative care unit and the usual care units10
COSA President's Welcome9
2021 COSA ASM Exhibitor Profiles9
8
8
2021 Hunter Cancer Research Symposium8
Consensus statements on the management of metastatic renal cell carcinoma from the Hong Kong Urological Association and the Hong Kong Society of Uro‐Oncology 20198
Rapid Fire presentation abstracts8
Poster Abstracts8
Olaparib dose re‐escalation in ovarian cancer patients who experienced severe and/or uncommon adverse events: A case series8
AUTHOR INDEX8
Suitability of endobronchial ultrasound‐guided transbronchial needle aspiration samples for programmed death ligand‐1 testing in non‐small cell lung cancer, the Bristol experience7
Poster Abstracts7
Management of rectal cancer in the era of total neoadjuvant therapy and watch and wait: A multidisciplinary team discussion at the Australasian Gastro‐Intestinal Trials Group (AGITG) Annual Scientific7
Issue Information7
Taxane‐based versus platinum‐based chemotherapy in early recurrent gastric cancer after radical surgery with S‐1 adjuvant chemotherapy: A multi‐institutional retrospective analysis7
Resilience and ongoing quality care for cancer clinical trials during COVID‐19: Experience from a tertiary hospital in Australia7
Association between financial toxicity and health‐related quality of life in cancer survivors: A systematic review7
Highlighted Lectures and Awards 20227
TNT: Raising more questions than answers?6
Treatment outcomes of patients with involved resection margin after rectal cancer surgery: A nationwide population‐based cohort study in South Korea6
Differences in ultrasonographic features between males and females with breast cancer of the luminal A and luminal B molecular subtypes6
Regorafenib outcomes from the population based South Australian Metastatic Colorectal Cancer Registry6
Hospitalizations in solid tumor phase I clinical trial patients: Incidence, pattern and clinical outcomes at an Australian phase I clinical trial unit6
Issue Information6
A smartphone program to support adherence to oral chemotherapy in people with cancer: Proof‐of‐concept trial6
The prognostic significance of immune checkpoint receptor expression in patients with lymphoma: Association with disease status and clinical outcomes6
Neo‐adjuvant FOLFIRINOX in borderline resectable and locally advanced pancreatic adenocarcinoma6
Clinical course of patients with renal cell carcinoma or urothelial carcinoma who had stable disease as an initial response to a PD‐1 or PD‐L1 inhibitor6
Phase 1 trial of intraperitoneal paclitaxel in combination with intravenous cisplatin and oral capecitabine in patients with advanced gastric cancer and peritoneal metastases (IPGP study)6
6
International Presenters5
ANZUP Chair Welcome5
5
Hong Kong Urological Association–Hong Kong Society of Uro‐Oncology consensus statements on the management of advanced prostate cancer—2019 Updates5
Malignant pericardial effusions: A retrospective look at etiology and prognosis in a tertiary oncological center5
Author Index5
A prospective phase II study of raltitrexed combined with S‐1 as salvage treatment for patients with refractory metastatic colorectal cancer5
Acknowledgements5
Retrospective review of safety and efficacy of anlotinib in advanced osteosarcoma with metastases after failure of standard multimodal therapy5
AUTHOR INDEX5
Invited speakers5
National Speakers5
Clinical results of total en bloc spondylectomy using a single posterior approach in spinal metastasis patients: Experiences from Thailand5
Stereotactic body radiotherapy prolongs the progression‐free survival and delays the change of systemic therapy regimen in patients with lung oligoprogressive metastatic colorectal cancer5
Comparison of weekly methotrexate regimen versus methotrexate folinic acid 8‐day regimen for treatment of low‐risk gestational trophoblastic neoplasia5
A prospective study of diagnostic accuracy of multidisciplinary team and radiology reporting of preoperative colorectal cancer local staging5
Issue Information5
Poster Abstracts5
Issue Information5
An Australian mainstream genetic testing program: Clinicians views about current and future practices5
T‐cell lymphoma patient harboring BCL11B mutations had favorable overall survival5
Maintenance chemotherapy in advanced and metastatic pancreatic cancer, a narrative review and case series5
Young Oncologist Oral Presentation Abstracts5
Issue Information5
Advancing ovarian cancer diagnosis: harnessing artificial intelligence and novel biomarker strategies4
Life‐threatening infections during treatment for acute lymphoblastic leukemia on the Malaysia‐Singapore 2003 and 2010 clinical trials: A risk prediction model4
If we build it, will they come? Modeling of public hospital care requirements for the Australian Bragg Centre for Proton Therapy and Research4
Fremantle protocol: Multicenter clinical outcomes for a pragmatic protocol for intravesical bacillus Calmette–Guerin4
Associations of body mass index and weight change with circulating levels of high‐sensitivity C‐reactive protein, proinflammatory cytokines, and adiponectin among breast cancer survivors4
The impact of coronavirus disease 2019 on genitourinary and prostate cancer care and clinical trials: A qualitative exploration of the Australian and New Zealand experience4
Centralization and prospective audit of cystectomy are necessary: a commentary on the case for centralization, supported by a contemporary series utilizing the ANZUP cystectomy database4
The Effectiveness of Afatinib as First‐Line Treatment in Vietnamese Patients With EGFR‐Mutant Non–Small Cell Lung Cancer and Brain Metastases4
Transcription factor KLF9 inhibits the proliferation, invasion, and migration of pancreatic cancer cells by repressing KIAA15224
Oral Abstracts4
Breast cancer treatment‐related arm lymphoedema and morbidity: A 6‐year experience in an Australian tertiary breast centre4
miR‐425 regulates ovarian cancer proliferation, metastasis, and apoptosis by repressing PAK4 expression4
Molecular basis and targeted therapies for radioiodine refractory thyroid cancer4
Prevalence and risk factors of chemotherapy‐induced oral mucositis among adult cancer patients at the cancer unit of Mbarara Regional Referral Hospital4
Nomogram based on the systemic immune‐inflammation index for predicting the prognosis of diffuse large B‐cell lymphoma4
Utilization of clinical practice guidelines for cancer care in routine practice and during the coronavirus disease 2019 pandemic in India4
2023 COSA ASM Exhibitor Profiles4
miRNA‐31 increases radiosensitivity through targeting STK40 in colorectal cancer cells4
Real‐world data on efficacy and safety of osimertinib in non‐small cell lung cancer patients with EGFR T790M mutation detected by first and repeat rebiopsy4
A proposed framework for the implementation of head and neck cancer treatment at a new cancer center from a radiation oncology perspective4
Issue Information3
2023 ANZUP Annual Scientific Meeting, 9‐11 July 2023, Melbourne Convention Centre, Victoria, Australia3
The molecular characteristics of non‐small cell lung cancer in the Northern Territory's Top End3
Increased TOX expression concurrent with PD‐1, Tim‐3, and CD244 in T cells from patients with non‐Hodgkin lymphoma3
Safety and efficacy of high‐dose cytarabine MEAM therapy and other treatments for auto‐peripheral blood stem cell transplantation: A retrospective comparative study3
Loss of CDX‐2 expression is an independent poor prognostic biomarker in patients with early‐stage deficient mismatch repair colorectal cancer3
Sponsor Acknowledgements3
COSA COMMITTEES3
Molecular Mechanisms of circKIF4A in Breast Cancer Progression3
COSA President's Welcome3
Incidence and risk factors for neoplasia in inflammatory bowel disease3
Effect of diabetes mellitus comorbidity on outcomes in stages II and III colorectal cancer3
TYK2 is a prognostic biomarker and associated with immune infiltration in the lung adenocarcinoma microenvironment3
Corrigendum3
The Case for Shared Decision‐making in Oncology and Why the Philippine Healthcare System is Primed for It3
Less aggressive treatment for less aggressive disease? A retrospective single‐center study of pulmonary‐limited metastases associated with colorectal cancer3
Issue Information3
3
Incidence and appropriate management of drug‐induced interstitial lung disease in Japanese patients with unresectable pancreatic cancer: A multicenter retrospective study3
Oral presentation abstracts3
Cyclophosphamide‐induced cardiotoxicity at conditioning for allogeneic hematopoietic stem cell transplantation would occur among the patients treated with 120 mg/kg or less3
Survival analysis for older patients with epidermal growth factor receptor mutation‐positive advanced non‐small cell lung cancer after progression of first‐line gefitinib3
Established the prediction model of early‐stage non‐small cell lung cancer spread through air spaces (STAS) by radiomics and genomics features3
Impact of Antibiotics and Chronic Medications on Efficacy of Immune Checkpoint Inhibitors in Patients With Hepatocellular Carcinoma3
Perceived importance of emotional support provided by health care professionals and social networks: Should we broaden our focus for the delivery of supportive care?3
3
Referral and uptake of services by distressed callers to the Cancer Council Information and Support telephone service3
The therapeutic effects of berberine for gastrointestinal cancers3
Trainee Oral Presentation Abstracts3
Cancer stem cell biomarkers SOX2 and Oct4 in cervical cancer patients undergoing chemoradiotherapy3
3
Telehealth adoption in cancer clinical trials: An Australian perspective3
Radioimmunotherapy with 131I‐rituximab for patients with relapsed or refractory follicular or mantle cell lymphoma3
Prevention and management of acneiform rash associated with EGFR inhibitor therapy: A systematic review and meta‐analysis3
International Speakers3
Prevention of docetaxel‐associated febrile neutropenia with primary granulocyte colony‐stimulating factor in Chinese metastatic hormone‐sensitive and castration‐resistant prostate cancer patients3
Overdiagnosis and overtreatment of ground‐glass nodule‐like lung cancer3
Issue Information3
Construction and validation of a novel tumor necrosis factor‐related apoptosis‐inducing ligand mutant MuR5S4‐TR3
Antithrombotic drug use does not affect the fecal immunochemical test PPV for colorectal cancer, but warfarin may have an impact in a Japanese cohort3
Exercise recommendations and referral patterns of oncology professionals3
The role of surveillance imaging for resected high‐risk melanoma3
Issue Information3
Adjuvant Radiotherapy After Surgical Resection Improves Local Control in Adrenocortical Carcinoma3
Prevalence of highly actionable mutations among Indian patients with advanced non‐small cell lung cancer: A systematic review and meta‐analysis2
2
Correlation of 18‐fluorodeoxyglucose uptake values on PET–CT scan with histological prognostic markers in breast cancer2
2
Real‐world management and patient perspectives on QOL with neuroendocrine tumors: An ANZ perspective2
Toxicity profile of patients treated with proton and carbon‐ion therapy for primary nasopharyngeal carcinoma: A systematic review and meta‐analysis2
Clinical outcomes of image‐guided percutaneous drainage of pericardial effusion in cancer patients: A single‐center retrospective analysis2
2
A risk factor analysis for local recurrence of bone and soft tissue sarcoma treated with carbon ion radiotherapy: A retrospective cohort study at a single institution2
Organising Committee2
Management of advanced prostate cancer in the Asia‐Pacific region: Summary of the Asia‐Pacific Advanced Prostate Cancer Consensus Conference 20232
Annual Scientific Meeting Program2
2
ANZUP MDT Masterclass Convenor Welcome2
Cost‐effectiveness analysis of human papillomavirus vaccines for the prevention of cervical cancer in India2
Sponsor Acknowledgments2
List of Poster Abstracts2
Issue Information2
2
Immune checkpoint inhibitors and tyrosine kinase inhibitors in patients with advanced hepatocellular carcinoma: Does the sequence matter?2
Frequency of germline BRCA1/2 mutations and association with clinicopathological characteristics in Turkish women with epithelial ovarian cancer2
Clinical outcomes and prognostic factors of cone‐beam CT‐guided radiofrequency ablation for pulmonary metastases in colorectal cancer patients2
Esophageal chemoradiotherapy with concurrent nivolumab: Pilot results in the palliative treatment of oligometastatic disease2
Program in Detail2
ANZUP Chair Welcome2
Real‐world multicenter study of the safety and efficacy of netupitant plus palonosetron fixed‐dose combination to prevent chemotherapy‐induced nausea and vomiting among Malaysian patients receiving mo2
Vigilance for carcinoid heart disease is still required in the era of somatostatin analogues: Lessons from a case series2
PD‐L1 heterogeneity in patients with non–small cell lung cancer2
Trainee Oral Presentation Abstracts2
Drug‐eluting bead transarterial chemoembolization with medium‐sized versus small‐sized CalliSpheres microspheres in unresectable primary liver cancer2
2
Issue Information2
ANZUP Fellowships and Awards2
2
Issue Information2
2
Poster Abstracts2
Pictorial essay on MRI local staging of rectal carcinoma: An easy approach2
Clinical application of preserving spontaneous breathing non‐intubation anesthesia in thoracoscopic surgery for lung cancer under ERAS concept2
Influencing factors of meaning in life in patients with advanced lung cancer undergoing radiochemotherapy: A cross‐sectional survey2
Organising Committee2
Screening for viral hepatitis B infection in cancer patients before receiving chemotherapy – A systematic review and meta‐analysis2
Issue Information2
Clinical and genetic characteristics of early‐stage multiple primary and independent primary lung adenocarcinoma patients2
External validation of the American Joint Committee on Cancer melanoma staging system eighth edition using the surveillance, epidemiology, and end results program2
Issue Information2
2023 COSA ASM Exhibitor Listing2
National Presenters and Chairs2
Does the number of cycles of neoadjuvant therapy affect the efficacy of neoadjuvant chemoimmunotherapy for non‐small cell lung cancer in locally advanced stage? Retrospective experience based on a sin2
Reliability and validity of the Cancer Health Literacy Test – Chinese versions: CHLT‐30‐Chinese and CHLT‐6‐Chinese2
Treatment patterns and long‐term survival outcomes for patients with stage III non‐small cell lung cancer: A retrospective study2
Awards and Scholarships2
International speakers2
0.11159205436707